Free Trial
OTCMKTS:BTCY

Biotricity (BTCY) Stock Price, News & Analysis

Biotricity logo
$0.53 +0.05 (+10.42%)
As of 03:51 PM Eastern

About Biotricity Stock (OTCMKTS:BTCY)

Key Stats

Today's Range
$0.48
$0.56
50-Day Range
$0.36
$0.63
52-Week Range
$0.19
$0.83
Volume
9,323 shs
Average Volume
48,278 shs
Market Capitalization
$13.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BTCY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biotricity and its competitors with MarketBeat's FREE daily newsletter.

BTCY Stock News Headlines

New law could create $3.7 trillion tsunami.
During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’s Project MAFA,” and it could soon return America to a “new” gold standard. The Trump administration, Wall Street, and Silicon Valley are all pushing it forward. The President himself calls the plan “incredible.” Already, it’s helping small plays jump as high as 300%, 318%, 520%, and even 600%.tc pixel
Rogue Funds’ New Holding: Biotricity (BTCY)
Biotricity Inc. Delays Yearly Report Filing
H.C. Wainwright Sticks to Their Hold Rating for Biotricity (BTCY)
Biotricity expands IP portfolio with 14 new patents
See More Headlines

BTCY Stock Analysis - Frequently Asked Questions

Biotricity's stock was trading at $0.2899 at the beginning of the year. Since then, BTCY shares have increased by 82.8% and is now trading at $0.53.

Biotricity Inc. (OTCMKTS:BTCY) issued its quarterly earnings data on Thursday, August, 14th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.09) by $0.06. The firm earned $3.87 million during the quarter, compared to the consensus estimate of $3.80 million.
Read the conference call transcript
.

Biotricity's stock reverse split before market open on Monday, July 3rd 2023.The 1-6 reverse split was announced on Monday, July 3rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, July 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 17 shares after the split.

Shares of BTCY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biotricity investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Broadcom (AVGO), Micron Technology (MU) and Bank of America (BAC).

Company Calendar

Last Earnings
8/14/2025
Today
8/22/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MEDICAL INFO SYS
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:BTCY
CIK
1630113
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.21)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.42 million
Net Margins
-37.33%
Pretax Margin
-37.32%
Return on Equity
N/A
Return on Assets
-94.07%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.24
Quick Ratio
0.15

Sales & Book Value

Annual Sales
$13.79 million
Price / Sales
0.90
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.32) per share
Price / Book
-0.38

Miscellaneous

Outstanding Shares
24,910,000
Free Float
22,396,000
Market Cap
$12.46 million
Optionable
Not Optionable
Beta
1.12
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (OTCMKTS:BTCY) was last updated on 8/22/2025 by MarketBeat.com Staff
From Our Partners